| human | Q5 |
| P268 | Bibliothèque nationale de France ID | 15092642s |
| P6178 | Dimensions author ID | 01017747433.03 |
| P269 | IdRef ID | 149965702 |
| P213 | ISNI | 0000000115626477 |
| P244 | Library of Congress authority ID | n2005181499 |
| P8189 | National Library of Israel J9U ID | 987007327991805171 |
| P691 | NL CR AUT ID | xx0190640 |
| P1207 | NUKAT ID | n2005107075 |
| P856 | official website | http://www.cvm.ncsu.edu/docs/personnel/gilger_brian.html |
| P496 | ORCID iD | 0000-0002-7771-9166 |
| P1053 | ResearcherID | D-8776-2014 |
| P214 | VIAF ID | 24894308 |
| P108 | employer | North Carolina State University | Q1132346 |
| P734 | family name | Gilger | Q5561784 |
| Gilger | Q5561784 | ||
| Gilger | Q5561784 | ||
| P101 | field of work | horse | Q726 |
| veterinary medicine | Q170201 | ||
| eye disease | Q3041498 | ||
| veterinary ophthalmology | Q113884054 | ||
| P735 | given name | Brian | Q15930574 |
| Brian | Q15930574 | ||
| P1412 | languages spoken, written or signed | English | Q1860 |
| P106 | occupation | veterinarian | Q202883 |
| university teacher | Q1622272 | ||
| ophthalmologist | Q12013238 | ||
| P21 | sex or gender | male | Q6581097 |
| Q91827746 | A Transient Developmental Background Finding in the Retina Observed in Neonatal Dogs in Juvenile Toxicology Studies |
| Q112718970 | A defect in the NOG gene increases susceptibility to spontaneous superficial chronic corneal epithelial defects (SCCED) in boxer dogs |
| Q54661001 | A moment of SCIENCE . . . Please! |
| Q44619508 | A novel bioerodible deep scleral lamellar cyclosporine implant for uveitis. |
| Q80219458 | A pharmacokinetic and safety evaluation of an episcleral cyclosporine implant for potential use in high-risk keratoplasty rejection |
| Q34094123 | A retrospective comparison of surgical removal and subsequent CO2 laser ablation versus topical administration of mitomycin C as therapy for equine corneolimbal squamous cell carcinoma. |
| Q44804277 | A topical aqueous calcineurin inhibitor for the treatment of naturally occurring keratoconjunctivitis sicca in dogs. |
| Q36602539 | AAV Gene Therapy for MPS1-associated Corneal Blindness |
| Q47108441 | AAV vector-meditated expression of HLA-G reduces injury-induced corneal vascularization, immune cell infiltration, and fibrosis. |
| Q44858578 | Anomalous nasolacrimal openings in a 2-year-old Morgan filly. |
| Q43078233 | Aqueous humor and plasma concentrations of ciprofloxacin and moxifloxacin following topical ocular administration in ophthalmologically normal horses. |
| Q40546933 | Bartonella vinsonii subspecies berkhoffi as a possible cause of anterior uveitis and choroiditis in a dog. |
| Q38781457 | Best practice recommendations for prehospital veterinary care of dogs and cats. |
| Q81512840 | Bilateral nodular lymphocytic conjunctivitis in a horse |
| Q34093992 | Carbon dioxide laser photoablation adjunctive therapy following superficial lamellar keratectomy and bulbar conjunctivectomy for the treatment of corneolimbal squamous cell carcinoma in horses: a review of 24 cases. |
| Q40332179 | Causes of endogenous uveitis in cats presented to referral clinics in North Carolina |
| Q44876195 | Clinical, histopathological and immunohistochemical characterization of a novel equine ocular disorder: heterochromic iridocyclitis with secondary keratitis in adult horses |
| Q39869870 | Comparison of capsular opacification and refractive status after placement of three different intraocular lens implants following phacoemulsification and aspiration of cataracts in dogs. |
| Q51575080 | Concerns with analysis of correlated eye data. |
| Q44865174 | Corrigendum to "Topical delivery of aqueous micellar Resolvin E1 analog (RX-10045)" [Int. J. Pharm. 498 (2016) 326-334]. |
| Q35844261 | Cosmetic globe surgery in the horse. |
| Q40445102 | Cytokine and chemokine profiles of aqueous humor and serum in horses with uveitis measured using multiplex bead immunoassay analysis. |
| Q35570183 | Diagnosis and treatment of lens diseases |
| Q44859940 | Diagnosis of intraocular lymphosarcoma in a dog by use of a polymerase chain reaction assay for antigen receptor rearrangement. |
| Q34284558 | Diode laser endoscopic cyclophotocoagulation in the normal equine eye. |
| Q33730401 | Effect of bone marrow-derived mesenchymal stem cells and stem cell supernatant on equine corneal wound healing in vitro |
| Q43428440 | Effect of choroidal perfusion on ocular tissue distribution after intravitreal or suprachoroidal injection in an arterially perfused ex vivo pig eye model. |
| Q33255696 | Effect of ophthalmic Nd:YAG laser energy on intraocular lenses after posterior capsulotomy in normal dog eyes. |
| Q43165352 | Effect of three treatment protocols on acute ocular hypertension after phacoemulsification and aspiration of cataracts in dogs. |
| Q40178093 | Efficacy of COX-2 inhibitors in controlling inflammation and capsular opacification after phacoemulsification cataract removal. |
| Q36410551 | Equine eosinophilic keratitis in horses: 28 cases (2003-2013). |
| Q35844234 | Equine glaucoma. |
| Q85182200 | Equine immune-mediated keratopathies |
| Q38200677 | Equine orbital fractures: a review of 18 cases (2006-2013). |
| Q56657603 | Equine recurrent uveitis: The viewpoint from the USA |
| Q82788161 | Equine special edition of veterinary ophthalmology |
| Q44857946 | Evaluation of 30- and 25-diopter intraocular lens implants in equine eyes after surgical extraction of the lens. |
| Q38903809 | Evaluation of Intracameral Pentablock Copolymer Thermosensitive Gel for Sustained Drug Delivery to the Anterior Chamber of the Eye. |
| Q44864817 | Evaluation of concentration of voriconazole in aqueous humor after topical and oral administration in horses. |
| Q34394093 | Evaluation of diode endoscopic cyclophotocoagulation in bovine cadaver eyes. |
| Q91609090 | Evaluation of equine corneal disease using spectral domain optical coherence tomography (SD-OCT) |
| Q44625127 | Extraocular lymphoma in the horse. |
| Q88328870 | Factors associated with postoperative complications in healthy horses after general anesthesia for ophthalmic versus non-ophthalmic procedures: 556 cases (2012-2014) |
| Q44866191 | Histiocytic chorioretinitis in a dog. |
| Q44875011 | Histopathological features of equine superficial, nonhealing, corneal ulcers |
| Q52688234 | Immune Relevant Models for Ocular Inflammatory Diseases. |
| Q37094236 | Immunology of the ocular surface. |
| Q40721836 | Impact of fungal species cultured on outcome in horses with fungal keratitis. |
| Q94955648 | In vitro susceptibility of Aspergillus and Fusarium associated with equine keratitis to new antifungal drugs |
| Q44878242 | International Equine Ophthalmology Consortium (IEOC) Symposium. |
| Q44867911 | Keratometry, biometry and prediction of intraocular lens power in the equine eye. |
| Q42441495 | Knockout of the aryl hydrocarbon receptor results in distinct hepatic and renal phenotypes in rats and mice. |
| Q44871858 | Low-dose oral administration of interferon-alpha for the treatment of immune-mediated keratoconjunctivitis sicca in dogs. |
| Q41702857 | Modified lamellar keratoplasties for the treatment of deep stromal abscesses in horses |
| Q64108746 | Multi-locus DNA sequence analysis, antifungal agent susceptibility, and fungal keratitis outcome in horses from Southeastern United States |
| Q36951932 | Multifocal electroretinogram in rhodopsin P347L transgenic pigs |
| Q44856397 | Nasal adenocarcinoma with diffuse metastases involving the orbit, cerebrum, and multiple cranial nerves in a horse. |
| Q46307338 | Nonclinical Development of ENV905 (Difluprednate) Ophthalmic Implant for the Treatment of Inflammation and Pain Associated with Ocular Surgery. |
| Q44762789 | Ocular distribution and toxicity of intravitreal injection of triamcinolone acetonide in normal equine eyes. |
| Q39723011 | Ocular parameters related to drug delivery in the canine and equine eye: aqueous and vitreous humor volume and scleral surface area and thickness. |
| Q47190882 | Optic neuritis in dogs: 96 cases (1983-2016). |
| Q97678257 | Optimizing corneal riboflavin administration in ex vivo horse, dog, rabbit, and pig samples for use in corneal collagen cross-linking |
| Q44856020 | Phacoemulsification and aspiration for cataract management in a dollar sunfish, Lepomis marginatus (Holbrook)--a case report. |
| Q48569812 | Pharmacologically defined components of the normal porcine multifocal ERG. |
| Q81320736 | Preclinical evaluation of a novel episcleral cyclosporine implant for ocular graft-versus-host disease |
| Q44877260 | Presumed primary ocular lymphangiosarcoma with metastasis in a miniature horse. |
| Q44861803 | Production of ELOVL4 transgenic pigs: a large animal model for Stargardt-like macular degeneration. |
| Q44857075 | Prognosis and impact of equine recurrent uveitis. |
| Q36848261 | Proteinases of the cornea and preocular tear film. |
| Q81150275 | Re: Recovery of canine retina and optic nerve function after acute elevation of intraocular pressure |
| Q44860580 | Retrobulbar pigmented peripheral nerve sheath tumor in a dog. |
| Q44873896 | Retrospective evaluation of phacoemulsification and aspiration in 41 horses (46 eyes): visual outcomes vs. age, intraocular lens, and uveitis status. |
| Q90724916 | Serotype survey of AAV gene delivery via subconjunctival injection in mice |
| Q44873744 | Spectral-domain optical coherence tomography evaluation of the cornea, retina, and optic nerve in normal horses |
| Q91331154 | Subconjunctival bone marrow-derived mesenchymal stem cell therapy as a novel treatment alternative for equine immune-mediated keratitis: A case series |
| Q44491258 | Superficial, nonhealing corneal ulcers in horses: 23 cases (1989-2003). |
| Q79804524 | Surgical removal of cataracts due to Diplostomum species in Gulf sturgeon (Acipenser oxyrinchus desotoi) |
| Q30824011 | Sustained Release of Protein Therapeutics from Subcutaneous Thermosensitive Biocompatible and Biodegradable Pentablock Copolymers (PTSgels) |
| Q44869669 | Sustained release cyclosporine therapy for bilateral keratoconjunctivitis sicca in a red wolf (Canis rufus). |
| Q42059809 | Sustained-release celecoxib from incubated acrylic intraocular lenses suppresses lens epithelial cell growth in an ex vivo model of posterior capsule opacity. |
| Q39670170 | The effect of topical administration of atropine sulfate on the normal equine pupil: influence of age, breed and gender. |
| Q37231179 | Topical delivery of aqueous micellar resolvin E1 analog (RX-10045) |
| Q35565484 | Topical, Aqueous, Clear Cyclosporine Formulation Design for Anterior and Posterior Ocular Delivery |
| Q44869053 | Treatment of immune-mediated keratitis in horses with episcleral silicone matrix cyclosporine delivery devices. |
| Q44300876 | Use of a hydroxyapatite orbital implant in a cosmetic corneoscleral prosthesis after enucleation in a horse. |
| Q53558849 | Use of episcleral cyclosporine implants in dogs with keratoconjunctivitis sicca: pilot study. |
| Q44874503 | Veterinary Ophthalmology - equine ophthalmology special issue. |
Search more.